Study of the Efficacy, Biodistribution, and Safety Profile of Therapeutic Gutless Adenovirus Vectors as a Prelude to a Phase I Clinical Trial for Glioblastoma

Glioblastoma multiforme (GBM) is the most common and most aggressive primary brain tumor in humans. Systemic immunity against gene therapy vectors has been shown to hamper therapeutic efficacy; however, helper-dependent high-capacity adenovirus (HC-Ad) vectors elicit sustained transgene expression,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Muhammad, AKMG, Puntel, M, Candolfi, M, Salem, A, Yagiz, K, Farrokhi, C, Kroeger, KM, Xiong, W, Curtin, JF, Liu, C, Lawrence, K, Bondale, NS, Lerner, J, Baker, GJ, Foulad, D, Pechnick, RN, Palmer, D, Ng, P, Lowenstein, PR, Castro, MG
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2908190/
https://ncbi.nlm.nih.gov/pubmed/20164833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2009.260
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados